QUATERNARY AMMONIUM SALTS AS M3 ANTAGONISTS Russian patent published in 2010 - IPC C07D413/12 C07D403/12 C07D413/14 A61K31/53 A61K31/42 A61K31/454 A61K31/497 A61P11/08 A61P29/00 A61P37/08 

Abstract RU 2394031 C2

FIELD: medicine.

SUBSTANCE: invention refers to new compounds of formula I in the form of salt where J means a C1-C2 alkylene; R1 means cyclopentane, cyclohexyl, phenyl or thiophenes; R2 means hydroxy; R3 means a cyclopentane, cyclohexyl, phenyl or thiophenes; with R1 and R3 are not identical, or -CR1R2R3 together form a group of the formula , where Ra means a chemical bond, and Rb means hydroxy; R4 means methyl; R5 means C1 alkyl substituted with -CO-NH-R6; R6 means 5- or 6-membered heterocyclic group that contains in a cycle at least one heteroatom selected from nitrogen, oxygen and sulfur; or J means C1-C2 alkylene; R1 and R3 both mean phenyl; R2 means hydroxy; R4 means methyl, R5 means C1 alkyl substituted with -CO-NH-R9; and R9 means 5- or 6-membered heterocyclic group that contains in a cycle at least one heteroatom selected from nitrogen, oxygen and sulfur. The invention also refers to pharmaceutical composition, to application of compound according to any of clauses 1-3, as well as to method for obtaining a compound of formula I according to clause 1.

EFFECT: obtaining new biologically active compounds having antagonistic activity against muscarinic receptor M3.

7 cl, 21 ex

Similar patents RU2394031C2

Title Year Author Number
PYRROLIDINIUM DERIVATIVES AS M3 MUSCARINIC RECEPTORS 2005
  • Press Nejl Dzhon
  • Kollingvud Stiven Pol
RU2412183C2
QUINUCLIDINE DERIVATIVES AND USE THEREOF AS M3 MUSCARINIC RECEPTOR ANTAGONISTS 2005
  • Press Nil Dzhon
  • Kollingvud Stiven Pol
  • Behttig Urs
  • Koks Brajan
  • Garad Sudkhakar Devidasrao
  • Kim Khenchul
  • Paputsakis Dimitris
  • Uotson Sajmon Dzhejms
RU2399620C2
NOVEL VANILLOID RECEPTOR LIGANDS AND USE THEREOF IN PRODUCING MEDICINAL AGENTS 2008
  • Frank Robert
  • Barenberg Gregor
  • Kristof Tomas
  • Shine Klaus
  • De-Vri Zhan
  • Sonders Derek
  • Pshevosni Mikhaehl'
  • Zundermann Bernd
  • Li Chzhiu
RU2487120C2
GUANIDINE-CONTAINING COMPOUNDS APPLICABLE AS MUSCARINIC RECEPTOR ANTAGONISTS 2008
  • Tszi Juj-Khua
  • Khasfeld Krehjg
  • Mu Juntsi
  • Li Rik
  • Li Li
RU2480458C2
(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS 2012
  • Ortega-Munos Alberto
  • Fajf Mattyu Kolin Tor
  • Martinel-Pedemonte Mark
  • Estyarte-Martines Mariya-De-Los-Ankheles
  • Vals-Vidal Nuriya
  • Kurs Guido
  • Kastro-Palomino-Lariya Khulio-Sesar
RU2668952C2
PHARMACEUTICAL COMPOSITION CONTAINING BENZODIAZEPINE DERIVATIVES AND RSV FUSION PROTEIN INHIBITOR 2005
  • Pauehll Kennet
  • Kelsi Richard
  • Karter Malkolm
  • Alber Dagmar
  • Uilson Lara
  • Khenderson Ehlajsa
  • Chambers Fil
  • Tejlor Debra
  • Tims Stehn
  • Daudell Veriti
RU2388476C2
UREA AND SULPHAMIDE DERIVATIVES AS TAFIA INHIBITORS 2007
  • Kallus Kristofer
  • Brenstrup Mark
  • Chekhtizkij Verngard
  • Ehfers Andreas
  • Foll'Mann Markus
  • Khallann Nis
  • Shrojder Kherman
RU2459619C2
SUBSTITUTED PHENYLSULFONAMIDE INHIBITORS OF BETA-AMYLOID SECRETION 2003
  • Kreft Ehntoni Frehnk
  • Koul Derek Sesil
  • Uoller Kevin Rodzher
  • Stok Dzhozef Rehjmond
  • Katterer Kristina Marta
  • Kubrak Dennis Majkl
  • Mann Charl'Z Uil'Jam
  • Mur Uil'Jam Dzhej
  • Kejsbir Dehvid Skott
RU2321394C2
DERIVANTS OF BICYCLO[2, 2, 1] HEPT-7-YLAMINE AND THEIR APPLICATIONS 2006
  • Finch Garri
  • Rehj Nikolas Charl'Z
  • Bull Richard Dzhejms
  • Van Nil Monik Bodil
  • Dzhenningz Ehndrju Stefen Robert
RU2442771C2
FLUORINE-18 AND CARBON-11 LABELED RADIOLIGANDS FOR POSITRON EMISSION TOMOGRAPHY (PET) IMAGING FOR LRRK2 2012
  • Chan Brajan K.
  • Estrada Entoni
  • Marik Yan
  • Svini Zakari Kevin
RU2650641C2

RU 2 394 031 C2

Authors

Press Nejl Dzhon

Kollingvud Stiven Pol

Dates

2010-07-10Published

2005-12-22Filed